INDUSTRY PROFILE The pharmaceutical sector- globally and in India- has been evolving rapidly. This industry has witnessed rapid transformation and growth. Especially in India, the growth has been significant. Starting from a rather small amount of Rs. 10 crore in the late 1940s, the pharmaceutical industry registered a turnover of over 6 billion dollars, as of 2004.
Till 1970, the pharmaceutical industry was dominated by multi-national companies. The drugs of these companies were patent protected. The industry was a monopoly of the foreign companies which had sophisticated R&D facilities. The MNC firms priced the pharmaceutical drugs at high price. The government of India passed the Indian patent act, 1970 and Drug price control order shifted patents from products to process.
The Indian pharmaceuticals market stands third in terms of volume and 14th largest in terms of value. In the Global Pharmaceutical Industry the total production of the sector is 20% in terms of vol. and 1.4% in terms of value. India is the leading supplier of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume . One of the major characteristics of this industry is that it is highly fragmented.
Those aren’t the only reasons I want to go into this profession, I really want to help people get well and feel better. A physician isn’t the only role that helps patients feel better. A pharmacist also has a key role. Pharmacists are healthcare providers that have to communicate with there patients to make sure they can take the medication properly according to their lifestyle, diet, and transportation. The best reason of all is that I get to work directly with patients.
PORTERS FIVE FORCES ANALYSIS - PHARMA INDUSTRY Using Porter's Five Forces we can analyse the scope of the pharmaceutical industry. It looks into five factors namely, competitive rivalry, threat of new entrants, threat of substitute products, bargaining power of suppliers and bargaining power of customers. " Competitive rivalry: The pharmaceutical industry is highly fragmented with almost 3,000 pharma companies and 10,500 manufacturing units. Due to increasing demand of high-quality drugs, low-to-moderate entry barrier to the new entrant, the presence of a number of large and small firm this market is highly competitive. With more drugs going off - patent, growth opportunities for the industry are expected to increase dramatically as generic
Over the years, the company went through some major mergers and acquisitions, transforming from Glaxo to Glaxo wellcome to GlaxoSmithKline. A final merger between Glaxo Wellcome and SmithKline Beecham in 2000 led to founding of GlaxoSmithKline. Considering the revenues as of March 14, 2014, GlaxoSmithKline was the 6th biggest pharmaceutical company in the world.  Moreover, as of May 2014, GSK boasted a market capitalization of £79 billion. With its corporate head office in London and operations in some 120 countries, GSK engages in creating, discovering, developing, manufacturing and marketing its consumer health-related and pharmaceutical products.
3. Introduction In every society, medicines are lifesaving, lifestyle-changing and health improving essential parts taken to cure illness in both physiologically and psychologically. The aim is to achieve a longer, improved quality of life by reducing pain and suffering of huge financial loss because medicines are not cheap. The home country of researcher is Myanmar (Burma). The
How do clinical pharmacists care for patients? Clinical pharmacists: • Provide a consistent process of patient care that ensures the appropriateness, effectiveness, and safety of the patient’s medication use. • Consult with the patient’s physician(s) and other health care provider(s) to develop and implement a medication plan that can meet the overall goals of patient care established by the health care team. • Apply specialized knowledge of the scientific and clinical use of medications, including medication action, dosing, adverse effects, and drug interactions, in performing their patient care activities in collaboration with other members of the health care team. • Call on their clinical experience to solve health problems through the rational use of medications.
MERGER OF GLAXO WELLCOME AND SMITHKLINE BEECHAM BY SARTHAK PUNYANI 13020841164 INTRODUCTION The reports talks about the Merger of Glaxo Wellcome and Smith Kline Beecham. This deal was considered as the merger among the equals. The merger took place in December 2000 after two years of long struggle between the two companies to come to a consensus. The then CEOs of Glaxo Wellcome (Richard Sykes) and SmithKline Beecham (Jan Leschly) did not want the companies to merge into single entities. But soon after Leschly declared his retirement the two companies came together to form what we now know as GlaxoSmithKline.
The share of Pakistan sports goods in total exports of Pakistan is 1.51% (2015-16) with football as major export product having 43% share of total sports goods exported in 2012-13 and major export of Pakistan sports goods are to Europe. This study is an attempt to analyze the contribution of sports goods industry in economic growth of Pakistan. This paper depicts importance of sports goods industry for Pakistan; it also analyzes the SWOT analysis of Pakistan sports goods industry, while various facts and figures are discussed as well. The Pakistan Sports goods and manufacturing association plays vital role in promotion of this industry. Although Sialkot, situated in the Punjab province of Pakistan, who is expert in producing and exporting sports goods and sport accessories all over the world since 100